Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeldin, Paraskevien_US
dc.contributor.authorLin, Chun-Yuen_US
dc.contributor.authorKolliopoulos, Constantinosen_US
dc.contributor.authorChen, Yen-Hsuen_US
dc.contributor.authorSkandalis, Spyros S.en_US
dc.date.accessioned2019-08-02T02:18:33Z-
dc.date.available2019-08-02T02:18:33Z-
dc.date.issued2019-05-01en_US
dc.identifier.issn0945-053Xen_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.matbio.2018.01.017en_US
dc.identifier.urihttp://hdl.handle.net/11536/152360-
dc.description.abstractThe tightly regulated biosynthesis and catabolism of the glycosaminoglycan hyaluronan, as well as its role in organizing tissues and cell signaling, is crucial for the homeostasis of tissues. Overexpression of hyaluronan plays pivotal roles in inflammation and cancer, and markedly high serum and tissue levels of hyaluronan are noted under such pathological conditions. This review focuses on the complexity of the regulation at transcriptional and posttranslational level of hyaluronan synthetic enzymes, and the outcome of their aberrant expression and accumulation of hyaluronan in clinical conditions, such as systemic B-cell cancers, aggressive breast carcinomas, metabolic diseases and virus infection. (C) 2018 Elsevier B.V. All rights reserved.en_US
dc.language.isoen_USen_US
dc.titleRegulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan productionen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.matbio.2018.01.017en_US
dc.identifier.journalMATRIX BIOLOGYen_US
dc.citation.volume78-79en_US
dc.citation.spage100en_US
dc.citation.epage117en_US
dc.contributor.department生醫工程研究所zh_TW
dc.contributor.departmentInstitute of Biomedical Engineeringen_US
dc.identifier.wosnumberWOS:000468707600008en_US
dc.citation.woscount5en_US
Appears in Collections:Articles